$CMRX
CHIMERIX INC

2022 Q3 Form 10-Q Financial Statement

#000111748022000036 Filed on August 08, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $32.56M $440.0K $15.00K
YoY Change 30325.23% 12.53% -98.95%
Cost Of Revenue $333.0K $0.00 $114.0K
YoY Change
Gross Profit $32.22M $440.0K -$99.00K
YoY Change 30014.02% 12.53% -106.9%
Gross Profit Margin 98.98% 100.0% -660.0%
Selling, General & Admin $5.313M $5.840M $5.632M
YoY Change 8.72% 32.49% 36.04%
% of Gross Profit 16.49% 1327.27%
Research & Development $15.26M $18.05M $19.04M
YoY Change 10.44% 30.79% 60.51%
% of Gross Profit 47.37% 4101.59%
Depreciation & Amortization $25.00K $24.00K $24.00K
YoY Change -34.21% -31.43% -66.2%
% of Gross Profit 0.08% 5.45%
Operating Expenses $20.58M $23.89M $24.67M
YoY Change 9.99% 31.2% -75.05%
Operating Profit $11.65M -$23.45M -$24.77M
YoY Change -162.61% 31.61% -74.58%
Interest Expense $199.0K -$21.00K $4.000K
YoY Change 397.5% -140.38% -90.0%
% of Operating Profit 1.71%
Other Income/Expense, Net
YoY Change
Pretax Income $241.5M -$23.47M -$24.77M
YoY Change -1401.27% 32.12% -74.58%
Income Tax $153.0K $0.00
% Of Pretax Income 0.06%
Net Earnings $241.4M -$23.47M -$24.77M
YoY Change -1400.44% 32.12% -74.58%
Net Earnings / Revenue 741.4% -5333.64% -165113.33%
Basic Earnings Per Share $2.75 -$0.27 -$0.28
Diluted Earnings Per Share $2.75 -$0.27 -$0.28
COMMON SHARES
Basic Shares Outstanding 87.62M shares 87.44M shares 87.09M shares
Diluted Shares Outstanding 87.81M shares 87.44M shares 87.09M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $284.6M $42.79M $53.38M
YoY Change 132.24% -67.59% -63.18%
Cash & Equivalents $274.3M $28.09M $31.96M
Short-Term Investments $10.37M $14.71M $21.42M
Other Short-Term Assets $6.022M $3.853M $5.766M
YoY Change 39.17% -7.93% 113.56%
Inventory $0.00 $4.126M $3.400M
Prepaid Expenses
Receivables $468.0K
Other Receivables $0.00
Total Short-Term Assets $291.1M $50.77M $62.55M
YoY Change 126.49% -62.74% -57.78%
LONG-TERM ASSETS
Property, Plant & Equipment $252.0K $205.0K $229.0K
YoY Change -4.55% -31.21% 5.05%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00
YoY Change -100.0%
Other Assets $430.0K $399.0K $439.0K
YoY Change 616.67% 1230.0% 1413.79%
Total Long-Term Assets $2.760M $2.793M $2.966M
YoY Change -43.3% -73.34% -71.78%
TOTAL ASSETS
Total Short-Term Assets $291.1M $50.77M $62.55M
Total Long-Term Assets $2.760M $2.793M $2.966M
Total Assets $293.9M $53.56M $65.52M
YoY Change 120.3% -63.49% -58.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.282M $1.743M $3.494M
YoY Change 83.15% 19.63% 60.2%
Accrued Expenses $14.43M $16.68M $11.72M
YoY Change 37.44% 76.25% 93.14%
Deferred Revenue $4.846M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $17.71M $23.27M $15.21M
YoY Change -32.64% -6.62% -31.63%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.218M $2.364M $2.506M
YoY Change -12.16% -10.93% -10.5%
Total Long-Term Liabilities $2.218M $2.364M $2.506M
YoY Change -12.16% -10.93% -10.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $17.71M $23.27M $15.21M
Total Long-Term Liabilities $2.218M $2.364M $2.506M
Total Liabilities $19.93M $25.64M $17.72M
YoY Change -30.84% -7.04% -29.13%
SHAREHOLDERS EQUITY
Retained Earnings -$692.5M -$933.8M -$910.4M
YoY Change -18.16% 12.84% 12.42%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $274.0M $27.93M $47.80M
YoY Change
Total Liabilities & Shareholders Equity $293.9M $53.56M $65.52M
YoY Change 120.3% -63.49% -58.7%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income $241.4M -$23.47M -$24.77M
YoY Change -1400.44% 32.12% -74.58%
Depreciation, Depletion And Amortization $25.00K $24.00K $24.00K
YoY Change -34.21% -31.43% -66.2%
Cash From Operating Activities $7.128M -$10.56M -$23.45M
YoY Change -146.62% -16.97% -38.13%
INVESTING ACTIVITIES
Capital Expenditures -$72.00K $0.00 $0.00
YoY Change 1340.0% -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities $238.3M $6.700M $53.47M
YoY Change 1441.16% 10.14% -160.32%
Cash From Investing Activities $238.3M $6.700M $53.47M
YoY Change 1441.2% 12.13% -160.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 778.0K -11.00K -$13.46M
YoY Change 39.68% -109.17% -112.05%
NET CHANGE
Cash From Operating Activities 7.128M -10.56M -$23.45M
Cash From Investing Activities 238.3M 6.700M $53.47M
Cash From Financing Activities 778.0K -11.00K -$13.46M
Net Change In Cash 246.2M -3.871M $16.56M
YoY Change 33668.86% -41.56% -211.07%
FREE CASH FLOW
Cash From Operating Activities $7.128M -$10.56M -$23.45M
Capital Expenditures -$72.00K $0.00 $0.00
Free Cash Flow $7.200M -$10.56M -$23.45M
YoY Change -147.11% -16.26% -38.25%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Local Phone Number
LocalPhoneNumber
806-1074
dei Entity Central Index Key
EntityCentralIndexKey
0001117480
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35867
dei Entity Registrant Name
EntityRegistrantName
CHIMERIX, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0903395
dei Entity Address Address Line1
EntityAddressAddressLine1
2505 Meridian Parkway
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
dei Entity Address City Or Town
EntityAddressCityOrTown
Durham
dei Entity Address State Or Province
EntityAddressStateOrProvince
NC
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
27713
dei City Area Code
CityAreaCode
919
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
CMRX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
87622853 shares
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28086000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15397000 usd
CY2022Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
14705000 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
72970000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
4126000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
2760000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3853000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4678000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
50770000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
95805000 usd
CY2022Q2 us-gaap Long Term Investments
LongTermInvestments
0 usd
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
2022000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
205000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
253000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2189000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2404000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
399000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
56000 usd
CY2022Q2 us-gaap Assets
Assets
53563000 usd
CY2021Q4 us-gaap Assets
Assets
100540000 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1743000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2788000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16682000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12933000 usd
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4846000 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
175000 usd
CY2022Q2 us-gaap Notes Payable Current
NotesPayableCurrent
0 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
14000000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
23271000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
29896000 usd
CY2022Q2 cmrx Loan Fees Liability Non Current
LoanFeesLiabilityNonCurrent
250000 usd
CY2021Q4 cmrx Loan Fees Liability Non Current
LoanFeesLiabilityNonCurrent
0 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2114000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2392000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
25635000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
32288000 usd
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 usd
CY2021Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
87436180 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
87436180 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
86884266 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
86884266 shares
CY2022Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
87000 usd
CY2021Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
87000 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
961740000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
953782000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-68000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-21000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-933831000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-885596000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
27928000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
68252000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
53563000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
100540000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
440000 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
391000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
455000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1826000 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
us-gaap Cost Of Revenue
CostOfRevenue
114000 usd
us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
440000 usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
391000 usd
us-gaap Gross Profit
GrossProfit
341000 usd
us-gaap Gross Profit
GrossProfit
1826000 usd
CY2022Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
18047000 usd
CY2021Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
13798000 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
37087000 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
25660000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5840000 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4408000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-17000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11472000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8544000 usd
CY2022Q2 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0 usd
CY2021Q2 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0 usd
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0 usd
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
82890000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
23887000 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
18206000 usd
us-gaap Operating Expenses
OperatingExpenses
48559000 usd
us-gaap Operating Expenses
OperatingExpenses
117094000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-23447000 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-17815000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-48218000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-115268000 usd
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-21000 usd
CY2021Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
52000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
90000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-23468000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-17763000 usd
us-gaap Net Income Loss
NetIncomeLoss
-48235000 usd
us-gaap Net Income Loss
NetIncomeLoss
-115178000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
5000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
32000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-47000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-11000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23463000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17731000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-48282000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-115189000 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.55
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.55
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.38
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.38
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
87436180 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
87436180 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
86225836 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
86225836 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
87263452 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
87263452 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
83231600 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
83231600 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
68252000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3708000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
102000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
555000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-52000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-24767000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-24819000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
47798000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3593000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
5000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-23468000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23463000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
27928000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
73376000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2584000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3530000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
330000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
43445000 usd
CY2021Q1 cmrx Equity Issuance Cost
EquityIssuanceCost
7200000 usd
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-97458000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
133649000 usd
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
107842000 usd
CY2021Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-43000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-97415000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3112000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
119000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
32000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-17763000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17731000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
119149000 usd
us-gaap Net Income Loss
NetIncomeLoss
-48235000 usd
us-gaap Net Income Loss
NetIncomeLoss
-115178000 usd
us-gaap Depreciation
Depreciation
48000 usd
us-gaap Depreciation
Depreciation
105000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
100000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-74000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-402000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
7301000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
5696000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
43445000 usd
us-gaap Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
0 usd
us-gaap Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
14000000 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
1000 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
2000 usd
cmrx Operating Lease Right Of Use Asset Amortization Expense And Straight Line Rent
OperatingLeaseRightOfUseAssetAmortizationExpenseAndStraightLineRent
46000 usd
cmrx Operating Lease Right Of Use Asset Amortization Expense And Straight Line Rent
OperatingLeaseRightOfUseAssetAmortizationExpenseAndStraightLineRent
292000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-304000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1365000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-917000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1832000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
7108000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2149000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-34007000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-50619000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
188000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
5258000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
100860000 usd
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
0 usd
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
7554000 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
7699000 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
2007000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
57726000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
23850000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
60167000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-82745000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
102000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3648000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
556000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
330000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
107842000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
129000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-14000000 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-13471000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
111820000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12689000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-21544000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15397000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46989000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28086000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25445000 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period amounts in the accompanying consolidated financial statements have been reclassified to conform to the current year presentation. These reclassifications had no effect on previously reported net income or stockholders' equity (deficit).</span></div>
CY2022Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
1800000 usd
CY2022Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2300000 usd
CY2022Q2 us-gaap Inventory Write Down
InventoryWriteDown
0 usd
us-gaap Inventory Write Down
InventoryWriteDown
100000 usd
CY2022Q2 cmrx Accrued Development Liabilities
AccruedDevelopmentLiabilities
9677000 usd
CY2021Q4 cmrx Accrued Development Liabilities
AccruedDevelopmentLiabilities
4642000 usd
CY2022Q2 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
3887000 usd
CY2021Q4 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
5491000 usd
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
741000 usd
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
359000 usd
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2377000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2441000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16682000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12933000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. In addition to estimates discussed in other sections of this Quarterly Report on Form 10-Q, the most significant estimates in the Company’s consolidated financial statements relate to the valuation of stock options and the valuation allowance for deferred tax assets resulting from net operating losses. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.</span></div>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
6 security
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
0 security
CY2022Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
6 security
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
46892000 usd
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
25000 usd
CY2022Q2 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
14773000 usd
CY2022Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2022Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
68000 usd
CY2022Q2 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
14705000 usd
CY2021Q4 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
75013000 usd
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
4000 usd
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
25000 usd
CY2021Q4 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
74992000 usd
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
13296000 usd
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
68000 usd
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
0 usd
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 usd
CY2022Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
13296000 usd
CY2022Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
68000 usd
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
0 usd
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 usd
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
46892000 usd
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
25000 usd
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
18 security
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
0 security
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
18 security
CY2022Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
14705000 usd
CY2022Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
14705000 usd
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y1M2D
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
100000 usd
CY2021Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
200000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
300000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
300000 usd
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0789
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
540000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2189000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2114000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
781000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
467000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3103000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
449000 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2654000 usd
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
637000 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2654000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
360000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
736000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
759000 usd
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
736000 usd
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
759000 usd
us-gaap Sublease Income
SubleaseIncome
12000 usd
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
781000 usd
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
467000 usd
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3380000 usd
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
556000 usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2824000 usd
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
200000 usd
CY2021Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
37000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
300000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
200000 usd
CY2022Q2 cmrx Lessee Operating Sublease Area Of Sublease Property
LesseeOperatingSubleaseAreaOfSubleaseProperty
3537 sqft
CY2021Q2 us-gaap Sublease Income
SubleaseIncome
0 usd
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
0 shares
us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
134000 shares
CY2021Q2 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
0 shares
us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
169000 shares
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3593000 usd
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3112000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7301000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5696000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1500000 usd

Files In Submission

Name View Source Status
0001117480-22-000036-index-headers.html Edgar Link pending
0001117480-22-000036-index.html Edgar Link pending
0001117480-22-000036.txt Edgar Link pending
0001117480-22-000036-xbrl.zip Edgar Link pending
a20220630cmrxex-311.htm Edgar Link pending
a20220630cmrxex-312.htm Edgar Link pending
a20220630cmrxex-321.htm Edgar Link pending
a20220630cmrxex-322.htm Edgar Link pending
cmrx-20220630.htm Edgar Link pending
cmrx-20220630.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
cmrx-20220630_def.xml Edgar Link unprocessable
cmrx-20220630_lab.xml Edgar Link unprocessable
cmrx-20220630_pre.xml Edgar Link unprocessable
cmrx-20220630_htm.xml Edgar Link completed
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cmrx-20220630_cal.xml Edgar Link unprocessable